Hepatic cholesterol crystals and crown-like structures distinguish NASH from simple steatosis

Journal of Lipid Research

Volumn 54, Issue 5, 2013, Pages 1326-1334

  Ioannou, George N ^a,b   Haigh, W Geoffrey ^a,b   Thorning, David ^c   Savard, Christopher ^a,b  

^a Division of Gastroenterology   (United States)

^b Veterans Affairs Puget Sound   (United States)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

Foam cells; Kupffer cells; Nonalcoholic steatohepatitis; Steatohepatitis

Indexed keywords

ALANINE AMINOTRANSFERASE; CHOLESTEROL; CRYOPYRIN; FAT DROPLET; FILIPIN; INFLAMMASOME; INSULIN; INTERLEUKIN 1BETA CONVERTING ENZYME; MESSENGER RNA;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASC GENE; BIREFRINGENCE; CASE REPORT; CASPASE 1 GENE; CELL ACTIVATION; CELL AGGREGATION; CHOLESTEROL DIET; CONTROLLED STUDY; CRYSTAL STRUCTURE; DISEASE COURSE; FATTY LIVER; FOAM CELL; GENE; HUMAN; HUMAN CELL; HUMAN TISSUE; KUPFFER CELL; LIPID ANALYSIS; LIVER CELL; MALE; MOUSE; NALP3 GENE; NONALCOHOLIC FATTY LIVER; NONHUMAN; PANNEXIN 1 GENE; PRIORITY JOURNAL;

ANIMALS; CELL AGGREGATION; CHOLESTEROL; DIAGNOSIS, DIFFERENTIAL; DIET, HIGH-FAT; FATTY LIVER; HEPATOCYTES; HUMANS; KUPFFER CELLS; LIPIDS; LIQUID CRYSTALS; MALE; MICE;

EID: 84876803994     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M034876     Document Type: Article

References (29)

1. Browning, J. D., L. S. Szczepaniak, R. Dobbins, P. Nuremberg, J. D. Horton, J. C. Cohen, S. M. Grundy, and H. H. Hobbs. 2004. Prevalence of hepatic steatosis in an urban population in the United States: Impact of ethnicity. Hepatology. 40 : 1387-1395.
2. Bellentani, S., G. Saccoccio, F. Masutti, L. S. Croce, G. Brandi, F. Sasso, G. Cristanini, and C. Tiribelli. 2000. Prevalence of and risk factors for hepatic steatosis in Northern Italy. Ann. Intern. Med. 132 : 112-117.
3. Williams, C. D., J. Stengel, M. I. Asike, D. M. Torres, J. Shaw, M. Contreras, C. L. Landt, and S. A. Harrison. 2011. Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: A prospective study. Gastroenterology. 140 : 124-131.
4. Matteoni, C. A., Z. M. Younossi, T. Gramlich, N. Boparai, Y. C. Liu, and A. J. McCullough. 1999. Nonalcoholic fatty liver disease: A spectrum of clinical and pathological severity. Gastroenterology. 116 : 1413-1419.
5. Bugianesi, E., N. Leone, E. Vanni, G. Marchesini, F. Brunello, P. Carucci, A. Musso, P. De Paolis, L. Capussotti, M. Salizzoni, et al. 2002. Expanding the natural history of nonalcoholic steatohepatitis: From cryptogenic cirrhosis to hepatocellular carcinoma. Gastroenterology. 123 : 134-140.
6. Matsuzawa, N., T. Takamura, S. Kurita, H. Misu, T. Ota, H. Ando, M. Yokoyama, M. Honda, Y. Zen, Y. Nakanuma, et al. 2007. Lipidinduced oxidative stress causes steatohepatitis in mice fed an atherogenic diet. Hepatology. 46 : 1392-1403.
7. Zheng, S., L. Hoos, J. Cook, G. Tetzloff, H. Davis, Jr., M. van Heek, and J. J. Hwa. 2008. Ezetimibe improves high fat and cholesterol diet-induced non-alcoholic fatty liver disease in mice. Eur. J. Pharmacol. 584 : 118-124.
8. Subramanian, S., L. Goodspeed, S. A. Wang, J. Kim, L. Zeng, G. N. Ioannou, W. G. Haigh, M. M. Yeh, K. V. Kowdley, K. D. O'Brien, et al. 2011. Dietary cholesterol exacerbates hepatic steatosis and inflammation in obese LDL receptor-deficient mice. J. Lipid Res. 52: 1626-1635.
9. Van Rooyen, D. M., C. Z. Larter, W. G. Haigh, M. M. Yeh, G. Ioannou, R. Kuver, S. P. Lee, N. C. Teoh, and G. C. Farrell. 2011. Hepatic free cholesterol accumulates in obese, diabetic mice and causes nonalcoholic steatohepatitis. Gastroenterology. 141: 1393-1403.
10. Ioannou, G. N., O. B. Morrow, M. L. Connole, and S. P. Lee. 2009. Association between dietary nutrient composition and the incidence of cirrhosis or liver cancer in the United States population. Hepatology. 50 : 175-184.
11. Yoneda, M., K. Fujita, Y. Nozaki, H. Endo, H. Takahashi, K. Hosono, K. Suzuki, H. Mawatari, H. Kirikoshi, M. Inamori, et al. 2010. Efficacy of ezetimibe for the treatment of non-alcoholic steatohepatitis: An open-label, pilot study. Hepatol. Res. 40 : 613-621.
12. Park, H., T. Shima, K. Yamaguchi, H. Mitsuyoshi, M. Minami, K. Yasui, Y. Itoh, T. Yoshikawa, M. Fukui, G. Hasegawa, et al. 2011. Efficacy of long-term ezetimibe therapy in patients with nonalcoholic fatty liver disease. J. Gastroenterol. 46 : 101-107.
13. Duewell, P., H. Kono, K. J. Rayner, C. M. Sirois, G. Vladimer, F. G. Bauernfeind, G. S. Abela, L. Franchi, G. Nunez, M. Schnurr, et al. 2010. NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals. Nature. 464 : 1357-1361.
14. Di Bisceglie, A. M., K. G. Ishak, L. Rabin, and J. M. Hoeg. 1990. Cholesteryl ester storage disease: Hepatopathology and effects of therapy with lovastatin. Hepatology. 11 : 764-772.
15. Kleiner, D. E., E. M. Brunt, M. Van Natta, C. Behling, M. J. Contos, O. W. Cummings, L. D. Ferrell, Y. C. Liu, M. S. Torbenson, A. Unalp-Arida, et al. 2005. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology. 41 : 1313-1321.
16. Savard, C., E. V. Tartaglione, R. Kuver, W. Geoffrey Haigh, G. C. Farrell, S. Subramanian, A. Chait, M. M. Yeh, L. S. Quinn, and G. N. Ioannou. 2013. Synergistic interaction of dietary cholesterol and dietary fat in inducing experimental steatohepatitis. Hepatology. 57: 81-92.
17. Rudolf, M., and C. A. Curcio. 2009. Esterifi ed cholesterol is highly localized to Bruch's membrane, as revealed by lipid histochemistry in wholemounts of human choroid. J. Histochem. Cytochem. 57 : 731-739.
18. Folch, J., M. Lees, and G. H. Sloane Stanley. 1957. A simple method for the isolation and purification of total lipides from animal tissues. J. Biol. Chem. 226 : 497-509.
19. Ganz, M., T. Csak, B. Nath, and G. Szabo. 2011. Lipopolysaccharide induces and activates the Nalp3 inflammasome in the liver. World J. Gastroenterol. 17 : 4772-4778.
20. Cinti, S., G. Mitchell, G. Barbatelli, I. Murano, E. Ceresi, E. Faloia, S. Wang, M. Fortier, A. S. Greenberg, and M. S. Obin. 2005. Adipocyte death defi nes macrophage localization and function in adipose tissue of obese mice and humans. J. Lipid Res. 46 : 2347-2355.
21. Strissel, K. J., Z. Stancheva, H. Miyoshi, J. W. Perfield 2nd, J. DeFuria, Z. Jick, A. S. Greenberg, and M. S. Obin. 2007. Adipocyte death, adipose tissue remodeling, and obesity complications. Diabetes. 56 : 2910-2918.
22. Wouters, K., M. van Bilsen, P. J. van Gorp, V. Bieghs, D. Lutjohann, A. Kerksiek, B. Staels, M. H. Hofker, and R. Shiri-Sverdlov. 2010. Intrahepatic cholesterol influences progression, inhibition and reversal of non-alcoholic steatohepatitis in hyperlipidemic mice. FEBS Lett. 584 : 1001-1005.
23. Wouters, K., P. J. van Gorp, V. Bieghs, M. J. Gijbels, H. Duimel, D. Lutjohann, A. Kerksiek, R. van Kruchten, N. Maeda, B. Staels, et al. 2008. Dietary cholesterol, rather than liver steatosis, leads to hepatic inflammation in hyperlipidemic mouse models of nonalcoholic steatohepatitis. Hepatology. 48 : 474-486.
24. Bieghs, V., F. Verheyen, P. J. van Gorp, T. Hendrikx, K. Wouters, D. Lutjohann, M. J. Gijbels, M. Febbraio, C. J. Binder, M. H. Hofker, et al. 2012. Internalization of modified lipids by CD36 and SR-A leads to hepatic inflammation and lysosomal cholesterol storage in Kupffer cells. PLoS ONE. 7 : E34378.
25. Bieghs, V., K. Wouters, P. J. van Gorp, M. J. Gijbels, M. P. de Winther, C. J. Binder, D. Lutjohann, M. Febbraio, K. J. Moore, M. van Bilsen, M. H., et al. 2010. Role of scavenger receptor A and CD36 in diet-induced nonalcoholic steatohepatitis in hyperlipidemic mice. Gastroenterology. 138: 2477-2486.
26. Bieghs, V., T. Hendrikx, P. J. van Gorp, F. Verheyen, Y. D. Guichot, S. M. Walenbergh, M. Gijbels, S. S. Rensen, A. Bast, J. Plat, et al. 2013. The cholesterol derivative 27-hydroxycholesterol reduces steatohepatitis in mice. Gastroenterology. 144: 167-178.
27. Dixon, L. J., M. Berk, S. Thapaliya, B. G. Papouchado, and A. E. Feldstein. 2012. Caspase-1-mediated regulation of fi brogenesis in diet-induced steatohepatitis. Lab. Invest. 92 : 713-723.
28. Walenbergh, S., T. Hendrikx, V. Bieghs, P. J. Van Gorp, M. M. Steinbusch, and R. Shiri-Sverdlov. 2012. The inflammasome as a novel target for the detection and treatment of non-alcoholic steatohepatitis (Abstract #1450 in The Liver Meeting. Boston, MA, November 9-13, 2012).
29. Wree, A., C. L. Johnson, A. Eguchi, H. M. Hoffman, and A. Feldstein. 2012. Constitutive mutant NLRP3 expression in myeloid cells leads to spontaneous liver inflammation and fibrosis (Abstract #1946 in The Liver Meeting. Boston, MA, November 9-13, 2012).